Hamps Bio Limited (BOM:544312)

Hamps Bio Statistics

Total Valuation

Hamps Bio has a market cap or net worth of INR 162.09 million. The enterprise value is 190.80 million.

Market Cap	162.09M
Enterprise Value	190.80M

Important Dates

The last earnings date was Friday, July 4, 2025.

Earnings Date	Jul 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Hamps Bio has 4.36 million shares outstanding. The number of shares has increased by 82.41% in one year.

Current Share Class	4.36M
Shares Outstanding	4.36M
Shares Change (YoY)	+82.41%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	71.99%
Owned by Institutions (%)	n/a
Float	1.22M

Valuation Ratios

The trailing PE ratio is 54.72.

PE Ratio	54.72
Forward PE	n/a
PS Ratio	2.43
PB Ratio	1.84
P/TBV Ratio	1.86
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.81, with an EV/FCF ratio of -4.31.

EV / Earnings	64.09
EV / Sales	2.86
EV / EBITDA	24.81
EV / EBIT	48.66
EV / FCF	-4.31

Financial Position

The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.34.

Current Ratio	2.26
Quick Ratio	0.69
Debt / Equity	0.34
Debt / EBITDA	3.86
Debt / FCF	-0.67
Interest Coverage	2.81

Financial Efficiency

Return on equity (ROE) is 4.89% and return on invested capital (ROIC) is 3.03%.

Return on Equity (ROE)	4.89%
Return on Assets (ROA)	2.73%
Return on Invested Capital (ROIC)	3.03%
Return on Capital Employed (ROCE)	3.59%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	73
Asset Turnover	0.74
Inventory Turnover	1.11

Taxes

In the past 12 months, Hamps Bio has paid 1.06 million in taxes.

Income Tax	1.06M
Effective Tax Rate	26.28%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	42.39
200-Day Moving Average	n/a
Relative Strength Index (RSI)	39.72
Average Volume (20 Days)	6,400

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hamps Bio had revenue of INR 66.69 million and earned 2.98 million in profits. Earnings per share was 0.68.

Revenue	66.69M
Gross Profit	46.70M
Operating Income	3.92M
Pretax Income	4.04M
Net Income	2.98M
EBITDA	7.69M
EBIT	3.92M
Earnings Per Share (EPS)	0.68

Balance Sheet

The company has 957,000 in cash and 29.67 million in debt, giving a net cash position of -28.72 million or -6.59 per share.

Cash & Cash Equivalents	957,000
Total Debt	29.67M
Net Cash	-28.72M
Net Cash Per Share	-6.59
Equity (Book Value)	88.01M
Book Value Per Share	20.10
Working Capital	23.67M

Cash Flow

In the last 12 months, operating cash flow was -7.05 million and capital expenditures -37.19 million, giving a free cash flow of -44.24 million.

Operating Cash Flow	-7.05M
Capital Expenditures	-37.19M
Free Cash Flow	-44.24M
FCF Per Share	-10.16

Margins

Gross margin is 70.02%, with operating and profit margins of 5.88% and 4.46%.

Gross Margin	70.02%
Operating Margin	5.88%
Pretax Margin	6.06%
Profit Margin	4.46%
EBITDA Margin	11.53%
EBIT Margin	5.88%
FCF Margin	n/a

Dividends & Yields

Hamps Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-82.41%
Shareholder Yield	n/a
Earnings Yield	1.84%
FCF Yield	-27.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4